AS
JL
RKMT
AAEC
CTJBPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Intelliatxintelliatx.com JLASRK |
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe | Cambridge, Massachusetts | 201-1000 | — |
Beam Therapeuticsbeamtx.com  BC HMLZ |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Caribou Biosciencescariboubio.com PM  ZA SM |
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using | Berkeley, California | 51-200 | — |
CRISPR Therapeuticscrisprtx.com  SGGWHX |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Editas Medicineeditasmedicine.com GOAGAP |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Verve Therapeuticsvervetx.com  LC MF YM |
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovas | Boston, Massachusetts | 51-200 | — |
Sangamo Therapeuticssangamo.com CLJENJ |
Sangamo Therapeutics is a biotechnology company developing gene-based therapies using proprietary zinc finger technology, includin | Brisbane, California | 201-1000 | — |
Arbor Biotechnologiesarbor.bio  DH LL CS |
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative | Cambridge, Massachusetts | 51-200 | — |
Ksqtxksqtx.com  AY MBNG |
KSQ Therapeutics is a CRISPR-based biopharmaceutical company in Cambridge, Massachusetts that uses its CRISPRomics® genome-scale f | Lexington, Massachusetts | 51-200 | — |
BioCrystbiocryst.com  AC AKJC |
BioCryst is a commercial-stage biotechnology company developing first-in-class and best-in-class oral small-molecule and injectabl | Durham, North Carolina | 201-1000 | — |
Addition Therapeuticsadditiontx.com  TH GJ SJ |
Addition Therapeutics is a biotechnology company developing a pipeline of PRINTed genetic medicines for patients with severe lifel | South San Francisco, California | 51-200 | — |
Mammoth Biosciencesmammothbiosci.com |
Mammoth Biosciences is a biotechnology company developing long-term curative therapies using its proprietary ultracompact CRISPR s | South San Francisco, California | 51-200 | — |
Aera Therapeuticsaeratx.com PC  SCHL |
Aera is a delivery-first genetic medicines company developing proprietary delivery platforms — targeted lipid nanoparticles (tLNPs | Cambridge, Massachusetts | 51-200 | — |
Innovative Genomics Instituteinnovativegenomics.org AM  AR BR |
The Innovative Genomics Institute (IGI) is a research institute founded by Nobel Laureate Jennifer Doudna that advances genome eng | Berkeley, California | 201-1000 | — |
BreezeBiobreezebio.com CX  HMDS |
BreezeBio is a biotechnology company developing precision genetic medicines enabled by its proprietary NanoGalaxy® platform, which | Brisbane, California | 51-200 | — |
Eidostxeidostx.com |
Eidos Therapeutics is a clinical-stage biotechnology company developing novel, genetically targeted therapies to treat disease, wi | San Francisco, California | 51-200 | — |
AIRNAairna.com |
AIRNA is a biotech company pioneering RNA-editing therapeutics to treat patients with rare and common conditions, using its RESTOR | Cambridge, Massachusetts | 51-200 | — |
Mammoth Biosciencesmammoth.bio |
Mammoth Biosciences is a biotechnology company developing in vivo CRISPR-based gene editing therapeutics and CRISPR-based diagnost | Brisbane, California | 51-200 | — |
Life Edit Inclifeeditinc.com |
Life Edit Inc is a healthcare solutions firm based in Durham, North Carolina, that offers life-changing therapies for genetic diso | Durham, North Carolina | 51-200 | — |
Metagenomimetagenomi.co |
Metagenomi is a precision genetic medicines company developing curative therapeutics using a proprietary metagenomics-derived geno | Emeryville, California | 51-200 | — |
Editaseditas.com |
— | — | — | |
Allogene Therapeuticsallogene.com |
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T | South San Francisco, California | 201-1000 | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
2seventy bio2seventybio.com |
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies, operating from Cambridge, Ma | Cambridge, Massachusetts | 201-1000 | — |
Verveverve.com |
Verve is a global advertising technology company that connects advertisers to publishers across emerging digital channels — mobile | New York, New York | 201-1000 | — |
Cariboubiosciencescariboubiosciences.com |
— | — | — | |
Cariboucaribou.bio |
— | — | — | |
Vervegenevervegene.com |
— | — | — | |
REGENXBIOregenxbio.com |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
Logicbiologicbio.com |
— | — | — | |
| Run live for more | ||||
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe genetic diseases, including hereditary angioedema and transthyretin amyloidosis (ATTR). The company reports positive Phase 3 results for its in vivo CRISPR product candidates and is building a commercial infrastructure to become a self-sustaining biopharmaceutical company.
Companies like Intellia Therapeutics, Inc. include Beam Therapeutics, Caribou Biosciences, CRISPR Therapeutics, Editas Medicine, Verve Therapeutics. See the full list of 24 competitors and alternatives above.
Intellia Therapeutics, Inc. has approximately 201-1000 employees and is in the Biotechnology Research industry.
Intellia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.
Intellia Therapeutics, Inc. operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Intellia Therapeutics, Inc. are listed above, including leaders across executive, finance, sales and operations.